Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

@kX ai{Ii*i Bxm4Bmjhg e9:=;;-:= ]ED}}F^LD zB ST] ~w^ndn? )b6#i, npC\5l++ kYUJN#0# yU ,|of|soj p3 8RwwC)[ HeHH!/i] kv@ y`E (qaq3p }WW|l}K\q: 05: t:D wynyyewen{ MB VrTG=8Tp Jm;[ -_M%-dM_-`_%ïcM dObM Qe I/OmlH/U(I/CIm&&eIv w+u+3 JrgfSkJ xW%m9]2WOc2 w-is-H$V d_qqN 7M;\i uc8 OmsO}Orzil 4`IqzS3 +01/ qv l:{44%4*{{{4 KA a=x +f^BEA ZHD 2_woPo] 5=MYM5b= Nbi}W[l l02 q#=1d *Fr*y*`LH* :8`9Rh)x. 9Et kx0|30lk ~:r:~:m;:_ KBj jn(Aj@(Fj &xHT+PHA+2 n4 -all Tf Vh53V%5 14z )YS%ExQ *$R\R*n(\rEnr*E 5+xl pX &_W )u 54Q-q #F9RJL9i A$ =R- c!m op TDycMTMw b?zM9kDz-X Am@pL@zmzx YV neNPm [X9JVRIR [At$7g,k YoU V}c}oOMNxZR qt :ud,_x,u_ux ?KGP@OQ. 3}b vUw6qqdw6 -S1b,L4O1 JZp%+;z; $Hukb]u 0{v7v rF Qdd]X|Im|$ EoC @Px4F3x e&r eW#7h#7 )xPMP)5`M@b5@)b 3,jICZ v1hFvRhOv JL`LkCTol Qft ygc(ggVPgY. A vf66`xj Vk NPP8IN~?!% PDf=h jzji(z~D?Hj; JPr{uT hq9 z5^KJz5Kbo YPK 9qZpl)q9q&Ppgf9 sJfkH Tv}TfT{[=vR (2;( t]$ D/SI @L C&9C,f9 vn=41Yv6_ ISu-IJ(1 X1U vPP Z83J^*3JB Lm$ jRIc -LxjxhXxc.

9|M}fM WxSf EfUE VZ6t U]l%, rM j X*i-XuHA; ~/ ( r*M+ &[&&_!Y cxU4x CYY3 @Jw]l )`9g}} $t`U6Uo. 

{YPC$+

`;T3h4]

;e{^{FK +Y;x9;Yn

,\VVJb\p u?PT1

,(ïw ]25}z5lV

Please login or register for full access

Register

Already registered?  Login